{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:15:17Z","timestamp":1788225317578,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinre.2026.102879","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:37:44Z","timestamp":1783010264000},"page":"102879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating performance of non-invasive tests for fibrosis detection in MASLD with Type 2 Diabetes Mellitus: Insights from VCTE-Based assessment"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9062-2484","authenticated-orcid":false,"given":"Yusuf","family":"Kagzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3655-5094","authenticated-orcid":false,"given":"Abuzar","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonu","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.clinre.2026.102879_bib0001","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MASLD: how is it different from MASLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102879_bib0002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis\u2014Aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102879_bib0003","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"Global epidemiology of MASLD and MASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102879_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2026.102879_bib0005","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2337\/dc22-2048","article-title":"High prevalence of MASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT","volume":"46","author":"Castera","year":"2023","journal-title":"Diab Care"},{"issue":"6","key":"10.1016\/j.clinre.2026.102879_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178473","article-title":"Liver biopsy in type 2 diabetes mellitus: steatohepatitis represents the sole feature of liver damage","volume":"12","author":"Masarone","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clinre.2026.102879_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000904","article-title":"Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications","volume":"8","author":"Ciardullo","year":"2020","journal-title":"BMJ Open Diab Res Care"},{"issue":"2","key":"10.1016\/j.clinre.2026.102879_bib0008","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2337\/dc20-1778","article-title":"High prevalence of advanced liver fibrosis assessed by transient elastography among US adults with type 2 diabetes","volume":"44","author":"Ciardullo","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.clinre.2026.102879_bib0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3350\/cmh.2020.0081","article-title":"Is liver biopsy still useful in the era of non-invasive tests?","volume":"26","author":"Lim","year":"2020","journal-title":"Clin Mol Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2026.102879_bib0011","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/apt.17997","article-title":"Prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States","volume":"59","author":"Mittal","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.clinre.2026.102879_bib0012","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cgh.2022.04.014","article-title":"Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"21","author":"Ng","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102879_bib0013","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for NAFLD\/NASH","volume":"20","author":"Sumida","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102879_bib0014","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan CAP and liver stiffness measurement in NAFLD","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinre.2026.102879_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/liv.14669","article-title":"Prognostic accuracy of FIB-4, MASLD fibrosis score and APRI","volume":"41","author":"Lee","year":"2021","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.clinre.2026.102879_bib0016","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on NAFLD","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1016\/j.clinre.2026.102879_bib0017","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.3350\/cmh.2022.0336","article-title":"Screening strategy for non-alcoholic fatty liver disease","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2026.102879_bib0018","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102879_bib0020","doi-asserted-by":"crossref","first-page":"e1456","DOI":"10.1016\/j.cgh.2021.06.048","article-title":"Global survey of physician knowledge about NAFLD","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.clinre.2026.102879_bib0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11894-023-00883-8","article-title":"Screening, diagnosis, and staging of MASLD: application of society guidelines","volume":"25","author":"Ilagan-Ying","year":"2023","journal-title":"Curr Gastroenterol Rep"},{"issue":"11","key":"10.1016\/j.clinre.2026.102879_bib0022","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and MASLD fibrosis scores","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2026.102879_bib0019","first-page":"133","article-title":"Universal Index for cirrhosis (UIC index)","volume":"10","author":"Ahmed","year":"2018","journal-title":"Hepat Med"},{"issue":"2","key":"10.1016\/j.clinre.2026.102879_bib0023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/life11020143","article-title":"FIB-4 first in the diagnostic algorithm of MASLD","volume":"11","author":"Sumida","year":"2021","journal-title":"Life"},{"issue":"7","key":"10.1016\/j.clinre.2026.102879_bib0024","first-page":"477","article-title":"APRI as a marker for advanced fibrosis","volume":"101","author":"Kruger","year":"2011","journal-title":"S Afr Med J"},{"issue":"8","key":"10.1016\/j.clinre.2026.102879_bib0025","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3748\/wjg.v19.i8.1219","article-title":"MASLD fibrosis score as a prognostic predictor","volume":"19","author":"Treeprasertsuk","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102879_bib0026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2026.102879_bib0027","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2019.04.020","article-title":"Sequential combinations of non-invasive fibrosis tests","volume":"71","author":"Boursier","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2026.102879_bib0028","article-title":"GLP-1 receptor agonists in NAFLD","volume":"27","author":"Muzurovi\u0107","year":"2022","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.clinre.2026.102879_bib0029","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography in NAFLD","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2026.102879_bib0030","series-title":"Investigating the natural history of liver disease in type 2 diabetes and predicting the risk of its progression to advanced disease","author":"Grecian","year":"2021"},{"issue":"2","key":"10.1016\/j.clinre.2026.102879_bib0031","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12072-018-09926-z","article-title":"Race\/ethnicity-based changes in MASLD-related advanced fibrosis","volume":"13","author":"Kim","year":"2019","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.clinre.2026.102879_bib0032","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in NAFLD","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"20","key":"10.1016\/j.clinre.2026.102879_bib0033","article-title":"Accuracy of FIB-4 to detect elevated liver stiffness","volume":"23","author":"Vigan\u00f2","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.clinre.2026.102879_bib0035","article-title":"Modified APRI for advanced fibrosis prediction","volume":"45","author":"Huang","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102879_bib0036","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1007\/s11695-020-04509-0","article-title":"Noninvasive fibrosis scores in morbid obesity","volume":"30","author":"Meneses","year":"2020","journal-title":"Obes Surg"},{"issue":"1","key":"10.1016\/j.clinre.2026.102879_bib0037","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12933-022-01483-y","article-title":"Hepatic steatosis, fibrosis, and cardiovascular outcomes","volume":"21","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"39","key":"10.1016\/j.clinre.2026.102879_bib0038","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.3748\/wjg.v30.i39.4324","article-title":"Non-invasive assessment of MASLD","volume":"30","author":"Singh","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102879_bib0039","article-title":"Limitations of non-invasive tests for liver fibrosis","volume":"2","author":"Patel","year":"2020","journal-title":"JHEP Rep"},{"issue":"7","key":"10.1016\/j.clinre.2026.102879_bib0040","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ajg.2016.65","article-title":"3D magnetic resonance elastography in MASLD","volume":"111","author":"Loomba","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102879_bib0041","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/jgh.15482","article-title":"Accuracy of the enhanced liver fibrosis test","volume":"36","author":"Sharma","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2026.102879_bib0042","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C","volume":"73","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2026.102879_bib0043","doi-asserted-by":"crossref","first-page":"i4428","DOI":"10.1136\/bmj.i4428","article-title":"Non-alcoholic fatty liver disease: NICE guidance summary","volume":"354","author":"Glen","year":"2016","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.clinre.2026.102879_bib0044","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FAST score for identification of NASH","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102879_bib0045","first-page":"51","article-title":"Efficacy and safety of fibroblast growth factor 21 analogues for metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis","volume":"81","author":"Dolovitsch de Oliveira","year":"2025","journal-title":"Annals Nutri Meta"},{"issue":"8","key":"10.1016\/j.clinre.2026.102879_bib0046","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and NASH (LITMUS project)","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.clinre.2026.102879_fur1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/apt.17688","article-title":"Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis","volume":"58","author":"Poynard","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.clinre.2026.102879_fur2","first-page":"101420","article-title":"Comparison of fibrosis scores in type 2 diabetes","volume":"49","author":"Vidal-Tr\u00e9can","year":"2023","journal-title":"Diab Metab"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:47:11Z","timestamp":1788223631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126001257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2210740126001257"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102879","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating performance of non-invasive tests for fibrosis detection in MASLD with Type 2 Diabetes Mellitus: Insights from VCTE-Based assessment","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102879"}}